These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 26240571)

  • 1. Applications of Induced Pluripotent Stem Cells in Studying the Neurodegenerative Diseases.
    Wan W; Cao L; Kalionis B; Xia S; Tai X
    Stem Cells Int; 2015; 2015():382530. PubMed ID: 26240571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Pluripotent Stem Cells in Neurodegenerative Diseases: Potentials, Advances and Limitations.
    Kolagar TA; Farzaneh M; Nikkar N; Khoshnam SE
    Curr Stem Cell Res Ther; 2020; 15(2):102-110. PubMed ID: 31441732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial dysfunction in neurodegenerative diseases: A focus on iPSC-derived neuronal models.
    Trombetta-Lima M; Sabogal-Guáqueta AM; Dolga AM
    Cell Calcium; 2021 Mar; 94():102362. PubMed ID: 33540322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges.
    Poon A; Zhang Y; Chandrasekaran A; Phanthong P; Schmid B; Nielsen TT; Freude KK
    N Biotechnol; 2017 Oct; 39(Pt B):190-198. PubMed ID: 28579476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling Human Neurological and Neurodegenerative Diseases: From Induced Pluripotent Stem Cells to Neuronal Differentiation and Its Applications in Neurotrauma.
    Bahmad H; Hadadeh O; Chamaa F; Cheaito K; Darwish B; Makkawi AK; Abou-Kheir W
    Front Mol Neurosci; 2017; 10():50. PubMed ID: 28293168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances of induced pluripotent stem cells application in neurodegenerative diseases.
    Amin N; Tan X; Ren Q; Zhu N; Botchway BOA; Hu Z; Fang M
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109674. PubMed ID: 31255650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease.
    Wu YY; Chiu FL; Yeh CS; Kuo HC
    Open Biol; 2019 Jan; 9(1):180177. PubMed ID: 30958120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell therapy for Parkinson's disease: safety and modeling.
    Stoddard-Bennett T; Pera RR
    Neural Regen Res; 2020 Jan; 15(1):36-40. PubMed ID: 31535640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Parkinson's Disease through Personalized Medicine and Induced Pluripotent Stem Cells.
    Stoddard-Bennett T; Reijo Pera R
    Cells; 2019 Jan; 8(1):. PubMed ID: 30621042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reprint of "iPSCs, aging and age-related diseases".
    Isobe K; Cheng Z; Nishio N; Suganya T; Tanaka Y; Ito S
    N Biotechnol; 2015 Jan; 32(1):169-79. PubMed ID: 25479728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling.
    Hu Z; Pu J; Jiang H; Zhong P; Qiu J; Li F; Wang X; Zhang B; Yan Z; Feng J
    Stem Cells Dev; 2015 Nov; 24(21):2591-604. PubMed ID: 26218671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. iPSCs, aging and age-related diseases.
    Isobe K; Cheng Z; Nishio N; Suganya T; Tanaka Y; Ito S
    N Biotechnol; 2014 Sep; 31(5):411-21. PubMed ID: 24784583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural stem cell-based treatment for neurodegenerative diseases.
    Kim SU; Lee HJ; Kim YB
    Neuropathology; 2013 Oct; 33(5):491-504. PubMed ID: 23384285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using induced pluripotent stem cells for modeling Parkinson's disease.
    Ke M; Chong CM; Su H
    World J Stem Cells; 2019 Sep; 11(9):634-649. PubMed ID: 31616540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory effects of stem cells: Therapeutic option for neurodegenerative disorders.
    Caprnda M; Kubatka P; Gazdikova K; Gasparova I; Valentova V; Stollarova N; La Rocca G; Kobyliak N; Dragasek J; Mozos I; Prosecky R; Siniscalco D; Büsselberg D; Rodrigo L; Kruzliak P
    Biomed Pharmacother; 2017 Jul; 91():60-69. PubMed ID: 28448871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential therapeutic applications of differentiated induced pluripotent stem cells (iPSCs) in the treatment of neurodegenerative diseases.
    Gao A; Peng Y; Deng Y; Qing H
    Neuroscience; 2013 Jan; 228():47-59. PubMed ID: 23069758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stepping back to move forward: a current review of iPSCs in the fight against Alzheimer's disease.
    Devineni A; Tohme S; Kody MT; Cowley RA; Harris BT
    Am J Stem Cells; 2016; 5(3):99-106. PubMed ID: 27853631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of treating neurodegenerative disease with induced pluripotent stem cells.
    Pen AE; Jensen UB
    Acta Neurol Scand; 2017 Jan; 135(1):57-72. PubMed ID: 26748435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.